G&L commits to further strategic growth with key appointments

G&L Scientific (G&L) has announced two transformative leadership appointments, reinforcing its commitment to becoming the healthcare and pharmaceutical industry’s premier Integrated Product Development and Market Access Platform.

These key additions bring decades of expertise and a shared vision to deliver cutting-edge solutions that enhance patient outcomes.

Joining as Vice President, Head of Integration, Philip McFerran will spearhead the integration of new companies into G&L’s growing network, ensuring seamless collaboration and operational synergy.

With an impressive career, including his tenure as Chief Operating Officer at Blackrock Pharmaceuticals, Philip is a proven leader in regulatory and quality operations.

His strategic acumen and focus on fostering cohesive teams will amplify the collective strengths of G&L’s partnerships, enabling the company to deliver comprehensive, end-to-end solutions across the product development lifecycle.

Meanwhile, Harry Graham has been appointed Vice President, Global Head of Strategic Alliances. In this role, Harry will focus on cultivating partnerships that drive innovation and sustained growth.

Bringing over 30 years of experience at leading organizations such as Fortrea, Labcorp Drug Development, Covance, and Merck, he is widely recognized for his expertise in acquisitions, portfolio management, and organizational transformation.

Harry’s leadership will empower G&L to forge impactful alliances, leverage global expertise, and provide clients with industry-leading solutions tailored to their needs.

Both appointments align closely with G&L’s commitment to delivering positive patient outcomes through a strategic combination of organic growth, partnerships, and acquisitions.

“Philip and Harry bring exceptional leadership and expertise that will be instrumental as we continue to evolve G&L into the leading Integrated Product Development Platform,” said Stephen Loughrey, CEO of G&L.

“Philip’s ability to drive operational synergies and Harry’s strength in building strategic alliances will shape our future, enabling us to support our clients at every stage of development.”

As G&L continues to grow, the expanded leadership team underscores its position as a trusted partner driving innovation and transformation across the healthcare and pharmaceutical landscape.

These appointments signal a confident step forward in the company’s mission to deliver unified, best-in-class solutions that improve lives worldwide.